Literature DB >> 15953144

Treatment of hemangiomas of infancy.

Victoria R Barrio1, Beth A Drolet.   

Abstract

Hemangiomas of infancy are the most common tumors of childhood. They are clinically heterogeneous and as such require individualized treatment plans. Although there are no Food and Drug Administration (FDA)-approved agents for treatment of hemangiomas of infancy, there are many widely used therapeutic options available. This review highlights the treatments currently in use and the factors that direct treatment.

Entities:  

Mesh：

Year:  2005        PMID： 15953144     DOI： 10.1111/j.1529-8019.2005.05018.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


  7 in total

1.  [Intraneural hemangioma of the ulnar nerve].

Authors:  C Brand; M T Pedro; M Schick; A Scheuerle; K Scheglmann; C R Wirtz; G Antoniadis
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

Review 2.  Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.

Authors:  Brittany G Craiglow; Richard J Antaya
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

Review 3.  Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Authors:  Beth A Drolet; Peter C Frommelt; Sarah L Chamlin; Anita Haggstrom; Nancy M Bauman; Yvonne E Chiu; Robert H Chun; Maria C Garzon; Kristen E Holland; Leonardo Liberman; Susan MacLellan-Tobert; Anthony J Mancini; Denise Metry; Katherine B Puttgen; Marcia Seefeldt; Robert Sidbury; Kendra M Ward; Francine Blei; Eulalia Baselga; Laura Cassidy; David H Darrow; Shawna Joachim; Eun-Kyung M Kwon; Kari Martin; Jonathan Perkins; Dawn H Siegel; Robert J Boucek; Ilona J Frieden
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124

4.  Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model.

Authors:  Dan Xu; Teresa M O; Archil Shartava; Taylor C Fowles; Jianchang Yang; Louis M Fink; David C Ward; Martin C Mihm; Milton Waner; Yupo Ma
Journal:  J Hematol Oncol       Date:  2011-12-22       Impact factor: 17.388

5.  Oral propranolol therapy in 23 infants with infantile hemangioma.

Authors:  Jaeyoon Kim; Jong Won Hong; Tai Suk Roh; Won Jai Lee
Journal:  Arch Plast Surg       Date:  2018-11-15

6.  Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers.

Authors:  Aoife Naughton; Ariel Yuhan Ong; Goran Darius Hildebrand
Journal:  Pediatr Rep       Date:  2021-07-01

Review 7.  Current perspectives on the optimal management of infantile hemangioma.

Authors:  Peter Grzesik; June K Wu
Journal:  Pediatric Health Med Ther       Date:  2017-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.